clinicaltrialsarena2h
Q32 Bio halts trials amid job cuts and pivots to alopecia treatment
Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...
clinicaltrialsarena4h
BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
BMS has reported that the Phase II TRANSCEND FL trial assessing Breyanzi, met its primary endpoint in the marginal zone ...
clinicaltrialsarena16h
Boehringer seeks approval of lung disease drug after second Phase III success
Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
clinicaltrialsarena21h
Radiopharm’s imaging molecule hits mark in observational trial
Radiopharm Theranostics’ RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a ...
clinicaltrialsarena23h
Regeneron’s macular oedema therapy shows promise in Phase III trial
Regeneron has reported positive outcomes from the Phase III trial of Eylea HD in treating individuals with macular oedema ...